BioRevolution
- All
- ETF Education
- Value Investing
- Fixed Income
- Inflation and Rising Rates
- Quality for Volatility
- Megatrends
- Emerging Markets
- Quality Dividend Growth
- Capital Efficiency
- Digital Assets
- Model Portfolios
- ESG
- BTM Podcast Series
- Advisor Solutions Series
- Women in Asset Management Series
- Index Rebalance Series
We recently spoke with Jamie Metzl, Founder and Chair of One Shared World, on how the coming decades could be impacted by the BioRevolution. Christopher Gannatti provides a recap of the discussion, which covered aspect of human development and generative artificial intelligence.
Read the article
Humans have been innovating as long as we’ve been around, but the pace of our innovation is now accelerating rapidly, especially within artificial intelligence and biology. Christopher Gannatti and Jamie Metzl outline five applications of the artificial intelligence revolution and the BioRevolution.
Read the article
Due to the Russia/Ukraine conflict and subsequent drought conditions, 2022 has been a difficult year for European agriculture. Christopher Gannatti discusses genetically modified crops and how this BioRevolutionary solution could help increase yields in a time of high inflation.
Read the article
July 28, 2022, was a historic day in both structural biology and artificial intelligence (AI), as AI continues to pave the way for exciting developments in the megatrend space. Christopher Gannatti outlines the latest advances.
Read the article
At WisdomTree, we believe that one of the biggest megatrends over the coming decades will relate to biotechnology. With an expanding global population and greater attention being paid to sustainability, novel approaches to agriculture may become an important focus in the long run. Christopher Gannatti discusses this growing megatrend.
Read the article
The new rate hike cycle has provided lower valuation entry points for investors seeking exposure to megatrends. Kara Marciscano gives an overview of a few of our megatrend Funds and recaps their recent performances.
Read the article
